ALT News and Press, Altimmune Inc.

2024-06-29 11:34:00 ET For most of its existence, Altimmune (NASDAQ: ALT) has been a little-known biotech aspiring to compete in a world dominated by whales like Novo Nordisk (NYSE: NVO) , the maker of the hit weight loss drug Wegovy and the blockbuster Ozempic for type 2 di...

2024-06-27 16:48:49 ET Summary The small biotech sector has badly underperformed the major market indices so far in 2024. However, that could change as the Federal Reserve cuts interest rates and/or M&A deal volume picks up across the industry. Today, we highlight three sm...

2024-06-26 07:44:59 ET More on Altimmune Altimmune: Lean Muscle Fat Data Sends Stock Soaring - Competitors Will Take Note Altimmune: Going All-In On Pemvidutide Altimmune: A Potential Minor Player In The Massive GLP-1 Space Biggest stock movers today: Crypto ...

GAITHERSBURG, Md., June 26, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Richard Eisenstadt, the Company’s Chief Financial Officer, passed away unexpectedly on Monday, June 24, 2024. “We are all sh...

2024-06-24 14:38:14 ET Summary Altimmune, Inc. shares surged nearly 30% after positive Phase 2 clinical study results for pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH. Pemvidutide may compete with Novo Nordisk's semaglutide and Eli Lilly's tirzepatide, ...

2024-06-24 12:06:59 ET More on DexCom, Tandem Diabetes Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here Dexcom: Positive Catalysts Ahead To Support Growth DexCom: Attractive Discount After Strong Earnings Results Tandem Diabetes Care...

2024-06-24 10:50:51 ET Wall Street’s major market averages traded in a mixed fashion on Monday, as tech struggles and Treasury yields noticed limited movement.... Read the full article on Seeking Alpha For further details see: Nasdaq, S&P, and Dow trade mixed as y...

A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...

2024-06-24 09:21:19 ET More on Altimmune Altimmune: Going All-In On Pemvidutide Altimmune: A Potential Minor Player In The Massive GLP-1 Space Altimmune's Pemvidutide Is Not To Be Dismissed Altimmune Q1 2024 Earnings Preview Altimmune falls after Q4 r...

2024-06-24 04:36:47 ET Altimmune (NASDAQ: ALT) stock price drifted upwards on Monday amid optimism that it will become a leading player in the weight loss industry. It rose by over 2%, meaning that it has soared by over 25% from the lowest point last week. Pemvidutide hopes rise ...